J Rheum Dis.  2020 Oct;27(4):247-260. 10.4078/jrd.2020.27.4.247.

Hyperuricemia is Associated With an Increased Prevalence of Metabolic Syndrome in a General Population and a Decreased Prevalence of Diabetes in Men

• Jeong H
• Moon JE
• Jeon CH

• KMID: 2506978
• DOI: http://doi.org/10.4078/jrd.2020.27.4.247

Abstract

Objective
. Elevated uric acid is associated with cardiovascular disease and metabolic syndrome. However, uric acid is also an antioxidant with beneficial effect on comorbidities. The aim of this study was to evaluate the relationship of serum uric acid with diabetes, metabolic syndrome, and cardiovascular disease in a Korean adult population. Methods. A total of 5,887 (weighted n=40,251,868) participants aged ≥19 years from the 2016 Korean National Health and Nutrition Examination Survey were included for analysis. Weighted prevalence and odds ratio (OR) of comorbidities were analyzed according to the presence of hyperuricemia and uric acid quartile. Results. Participants of both sexes with hyperuricemia showed higher prevalence of metabolic syndrome, hypertension, hypertriglyceridemia, and obesity than those without hyperuricemia. After adjusting for socioeconomic and lifestyle characteristics, hyperuricemia was associated with a decreased prevalence of diabetes mellitus in men (OR: 0.44, 95% confidence interval [CI]: 0.28∼0.72, p=0.001) and a decreased prevalence of myocardial infarction or angina (OR: 0.25, 95% CI: 0.08∼0.75, p=0.013) in women. Hyperuricemia was significantly associated with an increased prevalence of metabolic syndrome in both men (OR: 1.81, 95% CI: 1.33∼2.45, p＜0.001) and women (OR: 1.95, 95% CI: 1.22∼ 3.13, p=0.006). Conclusion. Hyperuricemia was associated with a decreased prevalence of diabetes mellitus in men and a decreased prevalence of myocardial infarction or angina in women. Hyperuricemia was associated with an increased prevalence of metabolic syndrome in both men and women.

Keyword

Uric acid; Metabolic syndrome; Diabetes mellitus

Reference

1. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. 2010; Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 62:170–80. DOI: 10.1002/acr.20065. PMID: 20191515. PMCID: PMC3156692.

2. Ford ES, Li C, Cook S, Choi HK. 2007; Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 115:2526–32. DOI: 10.1161/CIRCULATIONAHA.106.657627. PMID: 17470699.

3. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. 2008; High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 31:361–2. DOI: 10.2337/dc07-1276. PMID: 17977935.

4. Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. 2004; Prevalence of the metabolic syndrome in patients with gout. J Korean Rheum Assoc. 11:349–57.

5. Hong Q, Qi K, Feng Z, Huang Z, Cui S, Wang L, et al. 2012; Hyperuricemia induces endothelial dysfunction via mitochondrial Na⁺/Ca2⁺ exchanger-mediated mitochondrial calcium overload. Cell Calcium. 51:402–10. DOI: 10.1016/j.ceca.2012.01.003. PMID: 22361139.

6. Lyngdoh T, Marques-Vidal P, Paccaud F, Preisig M, Waeber G, Bochud M, et al. 2011; Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One. 6:e19901. DOI: 10.1371/journal.pone.0019901. PMID: 21625475. PMCID: PMC3098830.

7. Strazzullo P, Puig JG. 2007; Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis. 17:409–14. DOI: 10.1016/j.numecd.2007.02.011. PMID: 17643880.

8. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. 2013; Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 62:3307–15. DOI: 10.2337/db12-1814. PMID: 24065788.

9. Cutler RG. 1984; Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species. Arch Gerontol Geriatr. 3:321–48. DOI: 10.1016/0167-4943(84)90033-5. PMID: 6532339.

10. Ames BN, Cathcart R, Schwiers E, Hochstein P. 1981; Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 78:6858–62. DOI: 10.1073/pnas.78.11.6858. PMID: 6947260. PMCID: PMC349151.

11. Iso T, Kurabayashi M. 2015; Extremely low levels of serum uric acid are associated with endothelial dysfunction in humans. Circ J. 79:978–80. DOI: 10.1253/circj.CJ-15-0232. PMID: 25787674.

12. Waring WS, McKnight JA, Webb DJ, Maxwell SR. 2006; Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes. 55:3127–32. DOI: 10.2337/db06-0283. PMID: 17065352.

13. Bandaru P, Shankar A. 2011; Association between serum uric acid levels and diabetes mellitus. Int J Endocrinol. 2011:604715. DOI: 10.1155/2011/604715. PMID: 22114591. PMCID: PMC3216382.

14. Oda E, Kawai R, Sukumaran V, Watanabe K. 2009; Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med. 48:1785–91. DOI: 10.2169/internalmedicine.48.2426. PMID: 19834269.

15. Barbieri L, Verdoia M, Schaffer A, Marino P, Suryapranata H, De Luca G. 2015; Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: a single-centre study. Atherosclerosis. 241:241–8. DOI: 10.1016/j.atherosclerosis.2015.03.030. PMID: 25818387.

16. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. 2014; Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 43:69–77. DOI: 10.1093/ije/dyt228. PMID: 24585853. PMCID: PMC3937975.

17. Jeong H, Baek SY, Kim SW, Park EJ, Lee J, Kim H, et al. 2019; C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: results from the Korea National Health and Nutrition Examination Survey. BMJ Open. 9:e029861. DOI: 10.1136/bmjopen-2019-029861. PMID: 31473619. PMCID: PMC6720331.

18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. 2005; Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 112:2735–52. DOI: 10.1161/CIRCULATIONAHA.105.169404. PMID: 16157765.

19. Roncal-Jimenez CA, Lanaspa MA, Rivard CJ, Nakagawa T, Sanchez-Lozada LG, Jalal D, et al. 2011; Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism. 60:1259–70. DOI: 10.1016/j.metabol.2011.01.008. PMID: 21489572. PMCID: PMC3137694.

20. Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. 2012; Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 287:40732–44. DOI: 10.1074/jbc.M112.399899. PMID: 23035112. PMCID: PMC3504786.

21. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al. 2011; Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 60:1258–69. DOI: 10.2337/db10-0916. PMID: 21346177. PMCID: PMC3064099.

22. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. VHM&PP Study Group. 2008; Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem. 54:273–84. DOI: 10.1373/clinchem.2007.094425. PMID: 18039719.

23. Cook DG, Shaper AG, Thelle DS, Whitehead TP. 1986; Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J. 62:1001–6. DOI: 10.1136/pgmj.62.733.1001. PMID: 3628142. PMCID: PMC2418956.

24. Reaven GM. 1997; The kidney: an unwilling accomplice in syndrome X. Am J Kidney Dis. 30:928–31. DOI: 10.1016/S0272-6386(97)90106-2. PMID: 9398143.

25. Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H. 1988; Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol. 127:321–36. DOI: 10.1093/oxfordjournals.aje.a114807. PMID: 3337086.

26. Choi HK, Ford ES. 2008; Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford). 47:713–7. DOI: 10.1093/rheumatology/ken066. PMID: 18390895.

27. Erdberg A, Boner G, van Dyk DJ, Carel R. 1992; Urine uric acid excretion in patients with insulin-dependent diabetes mellitus. Nephron. 60:134–7. DOI: 10.1159/000186728. PMID: 1552996.

28. Chou P, Lin KC, Lin HY, Tsai ST. 2001; Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheumatol. 28:571–6. PMID: 11296961.

29. Rodríguez G, Soriano LC, Choi HK. 2010; Impact of diabetes against the future risk of developing gout. Ann Rheum Dis. 69:2090–4. DOI: 10.1136/ard.2010.130013. PMID: 20570836. PMCID: PMC3136217.

30. Wijnands JM, van Durme CM, Driessen JH, Boonen A, Klop C, Leufkens B, et al. 2015; Individuals with type 2 diabetes mellitus are at an increased risk of gout but this is not due to diabetes: a population-based cohort study. Medicine (Baltimore). 94:e1358. DOI: 10.1097/MD.0000000000001358. PMID: 26266391. PMCID: PMC4616721.

31. Wingrove CS, Walton C, Stevenson JC. 1998; The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism. 47:435–8. DOI: 10.1016/S0026-0495(98)90056-7. PMID: 9550542.

32. De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. 2010; Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis. 69:1162–4. DOI: 10.1136/ard.2009.122770. PMID: 20124358. PMCID: PMC3142935.

33. Liu M, He Y, Jiang B, Wu L, Yang S, Wang Y, et al. 2014; Association between serum uric acid level and metabolic syndrome and its sex difference in a Chinese community elderly population. Int J Endocrinol. 2014:754678. DOI: 10.1155/2014/754678. PMID: 25136366. PMCID: PMC4129973.

34. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, et al. 2012; Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 220:525–31. DOI: 10.1016/j.atherosclerosis.2011.11.014. PMID: 22154195.

35. Quiñones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, et al. 1995; Effect of insulin on uric acid excretion in humans. Am J Physiol. 268(1 Pt 1):E1–5. DOI: 10.1152/ajpendo.1995.268.1.E1. PMID: 7840165.

36. Carnethon MR, Fortmann SP, Palaniappan L, Duncan BB, Schmidt MI, Chambless LE. 2003; Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol. 158:1058–67. DOI: 10.1093/aje/kwg260. PMID: 14630601.

37. Feig DI, Kang DH, Johnson RJ. 2008; Uric acid and cardiovascular risk. N Engl J Med. 359:1811–21. DOI: 10.1056/NEJMra0800885. PMID: 18946066.

38. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. 2000; Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension. 36:1072–8. DOI: 10.1161/01.HYP.36.6.1072. PMID: 11116127.

39. Gwag HB, Yang JH, Park TK, Song YB, Hahn JY, Choi JH, et al. 2017; Uric acid level has a u-shaped association with clinical outcomes in patients with vasospastic angina. J Korean Med Sci. 32:1275–80. DOI: 10.3346/jkms.2017.32.8.1275. PMID: 28665063. PMCID: PMC5494326.

40. Fang J, Alderman MH. 2000; Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA. 283:2404–10. DOI: 10.1001/jama.283.18.2404. PMID: 10815083.